Iovance Biotherapeutics, Inc. IOVA Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s software and technology licenses, net?
- Iovance Biotherapeutics, Inc. (IOVA) reported software and technology licenses, net of $8.29M in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s software and technology licenses, net changed year-over-year?
- Iovance Biotherapeutics, Inc.'s software and technology licenses, net increased by 1846.2% year-over-year, from $426K to $8.29M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s software and technology licenses, net?
- Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s software and technology licenses, net has grown at a -8.8% compound annual growth rate (CAGR), from $12.92M to $8.17M.